Capital Advisory Group Advisory Services’s Elevance Health ELV Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23	Closed	-$11K	–	288
2022 Q1	$11K	Buy	+23	New	+$10.5K	0.01%	359
2021 Q4	–	Sell	-23	Closed	-$9K	–	258
2021 Q3	$9K	Hold	23	–	–	﹤0.01%	401
2021 Q2	$9K	Hold	23	–	–	﹤0.01%	404
2021 Q1	$8K	Hold	23	–	–	﹤0.01%	404
2020 Q4	$7K	Hold	23	–	–	﹤0.01%	401
2020 Q3	$6K	Hold	23	–	–	﹤0.01%	362
2020 Q2	$6K	Hold	23	–	–	﹤0.01%	352
2020 Q1	$5K	Buy	+23	New	+$6.27K	0.01%	303
2019 Q4	–	Sell	-73	Closed	-$18K	–	263
2019 Q3	$18K	Sell	73 -79	-52%	-$21.6K	0.01%	218
2019 Q2	$42K	Buy	152 +23	+18%	+$6.28K	0.03%	164
2019 Q1	$37K	Sell	129 -229	-64%	-$66.2K	0.03%	164
2018 Q4	$96K	Sell	358 -419	-54%	-$115K	0.07%	106
2018 Q3	$213K	Buy	777 +727	+1,454%	+$189K	0.14%	81
2018 Q2	$12K	Buy	+50	New	+$11.6K	0.01%	228

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital Advisory Group Advisory Services's ELV Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 23 shares — an estimated $11K sold.

Capital Advisory Group Advisory Services first reported a position in ELV in Q2 2018 and held it in 14 quarters. The position peaked at $213K in Q3 2018. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Capital Advisory Group Advisory Services reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 23 Elevance Health shares in Q2 2022, an estimated $11K.
Capital Advisory Group Advisory Services first reported a position in Elevance Health in Q2 2018 and held it in 14 quarters.
Capital Advisory Group Advisory Services's Elevance Health position peaked at $213K in Q3 2018.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.